Latest Conference Articles

Answering all the questions ophthalmologists may have ahead of the EURETINA Congress in Paris, France

Retina specialists will celebrate the major anniversary this September in Paris, France.

Research reveals a significant link between androgen exposure and central serous chorioretinopathy, aiding clinicians in assessing patient risk factors effectively.

Research reveals that GLP-1 medications, including semaglutide, do not increase diabetic retinopathy risks, offering reassurance for patients and prescribers.

A look at podium presentations on GA research at ASRS 2025.

Omer Trivizki discusses promising results of VOY-101, a gene therapy for geographic atrophy, highlighting safety and next steps in ongoing research.

Extend the summer at EyeCon 2025—where clinical insight meets coastal vibes—September 26 and 27 at the Margaritaville Hollywood Beach Resort in Florida.

A 12-month follow-up indicated no dose limiting toxicity and no ocular or systemic adverse effects

Highlights from the 2025 Heidelberg Engineering International SPECTRALIS Symposium—And Beyond

João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases